THE PRECLINICAL VALIDATION OF RADIO-LABELLED GIRENTUXIMAB AS A THERANOSTIC AGENT IN METASTATIC COLORECTAL CANCER

Grant number: 1184859 | Funding period: 2020 - 2023

Active